Geftinat 250 mg

1. Overview
Geftinib is a targeted therapy used to treat certain types of non-small cell lung cancer (NSCLC). It works best in cancers that have specific mutations in the EGFR gene, helping to slow or stop cancer growth.

2. How It Works
Geftinib blocks the activity of the epidermal growth factor receptor (EGFR), a protein that signals cancer cells to grow and divide. By inhibiting this signal, it helps reduce tumor growth and spread.

3. Common Uses

• Non-small cell lung cancer (NSCLC) with EGFR mutations
• Advanced or metastatic NSCLC
• Sometimes used when standard chemotherapy is not effective

4. Key Benefits

• Targets cancer cells specifically with fewer effects on healthy cells
• Can slow tumor growth and improve quality of life
• Oral medication that is convenient to take at home

5. Safety & Precautions

• Take exactly as prescribed by your doctor
• Monitor for skin rash, diarrhea, or liver function changes
• Avoid smoking, as it can reduce the effectiveness of the medication
• Inform your doctor about other medications or health conditions

6. Scientific Literature (External Links)

• EGFR inhibitors in NSCLC: PubMed Link
• Mechanism and clinical efficacy: PubMed Link
• Gefitinib treatment guidelines: PubMed Link